Pfizer (PFE) Trades Below Its Own Average Multiple, Is It Cheap for a Reason?
Pfizer (NYSE:PFE) raised its revenue guidance in the second quarter of 2026, held its earnings guidance and announced another round of cost cuts. It also reported a loss of $0.04 a share.







